In their research, they conjugated the NODAGA chelator and bombesin peptide to PEGylated USPIONs to selectively target breast cancer cells (MDA-MB-231 and MCF-7) and deliver 68Ga-derived activity. Here, GRP is linked to breast carcinoma.